Variable | Value |
---|---|
Gender, M/F | 50/26 (66%/34%) |
Age at onset (years) | 50.0 (40–62) |
interval from onset to antifungal treatment (day) | 29 (15,40) |
duration of antifungal treatment (day) | 31 (12.5, 54.5) |
Am B administration | 69 (90.8%) |
Shunt surgery | 11 (14.5%) |
Main symptoms and signs | |
Headache | 71 (93.4%) |
Fever | 48 (63.2%) |
Vomiting | 38 (50.0%) |
Impaired consciousness | 15 (19.7%) |
Visual disturbance | 15 (19.7%) |
Seizures | 9 (11.8%) |
Limb weakness | 7 (9.2%) |
Altered mentation | 7 (9.2%) |
Hearing impairment | 2 (2.6%) |
Meningeal irritation positive | 45 (59.2%) |